Weed Found Effective To Treat Sickle Cell Disease Pain
The study’s results could have wide-reaching ramifications in that opioids are currently the primary treatment to ease the chronic and acute pain suffered by those afflicted with sickle cell disease (SCD).
Weed appears to be a secure and potentially effective treatment for the chronic pain that afflicts people with RBC disease, in keeping with a brand new run co-led. The study’s results, released July 17, 2020, could have wide-reaching ramifications in these opioids are currently the first treatment to ease the chronic and acute pain suffered by those afflicted with RBC disease (SCD). SCD may be a common inherited blood dyscrasia, also called RBC anemia in its more serious stage. The only cure for SCD is bone marrow or somatic cell transplant, per the Centers for Disease Control (CDC).
The rise in opioid-related deaths and addiction has prompted physicians to prescribe them less frequently, thereby leaving red blood cell patients with fewer and fewer treatment options. Gupta said that, additionally to the study at hand, the trial opened the door for testing different types of medical weed to treat chronic pain, including vaporized forms, which is what they utilized in the study. He noted that treating pain is that the top reason people cite for seeking weed from dispensaries. Of course, we still need larger studies with more participants to relinquish us a more robust picture of how hemp may benefit people with chronic pain.” The double-blind, placebo-controlled, randomized trial was the primary to use such gold-standard methods to assess weed’s potential for pain alleviation in people with red blood cell disease, noted promulgation from UCI’s Center for the Study of hemp. Researchers assessed participants’ pain levels throughout the treatment period and located that the effectiveness of weed, which contained equal parts THC and CBD, looked as if it would increase over time.